Sonus Microsystems and Kinetix Medicine Announce Partnership for Clinical Evaluation of Sonus’ Wearable Ultrasound Technology

FOR IMMEDIATE RELEASE: 

VANCOUVER, CANADA (October 7, 2025) -  Sonus Microsystems, developers of an AI-powered ultrasound wearable for autonomous on-demand ultrasound, today announced the company has entered a Collaboration Agreement with Kinetix Medicine (“Kinetix”). The purpose of the partnership is to evaluate the clinical application of the Sonus Patch, a wearable ultrasound patch representing a transformative advancement in medical diagnostic technology.

Under the agreement, Kinetix will conduct a clinical trial of the Sonus Patch, with enrollment expected to commence in 2026 and continue through 2027. The trial will be designed and executed by Kinetix in collaboration with Sonus. The commercial terms of the agreement have not been disclosed, although the companies note that the collaboration also includes commercial components.

“This collaboration represents a key milestone for Sonus as we move from technology development toward clinical validation,” said Dr. Hani Eskandari, CEO of Sonus Microsystems. “We believe this trial will generate critical data to support the use of the Sonus Patch as a new wearable device that allows patients to access continuous ultrasound monitoring.”

"This partnership also marks a significant milestone in our journey to improve patient monitoring by providing real-time AI-powered insights to enable healthcare providers to receive continuous, high-resolution imaging, even outside the medical setting,” said Eskandari.  

“This study represents an important step in validating a technology with the potential to transform patient monitoring,” said Dr. Sanjiv Bhalla, Diagnostic and Interventional Radiologist and Emergency Physician, Co-Founder and Medical Director, Kinetix. “The ability to obtain continuous imaging data directly from a wearable ultrasound patch could allow earlier detection of cardiac dysfunction, blood clots, or other life-threatening conditions, with broad implications for both acute and chronic care.”

According to Dr. Bhalla, “The real power of the Sonus technology is continuous physiologic insights enabling continuous monitoring in real time, which provides crucial information for early intervention. We also see exciting potential for its use in adjacent areas such as musculoskeletal disorders, where continuous monitoring could provide valuable insights for both patients and clinicians.”

The collaboration with Kinetix underscores Sonus’s strategy to gather clinical evidence in support of the company's proprietary Sonus Array Technology™, while preparing for future commercial applications.

About Sonus Microsystems

Sonus Microsystems is an innovative MedTech company leading the advancement of ultrasound technology. The company is developing a wearable ultrasound patch designed to provide new possibilities in remote cardiac monitoring. Leveraging its proprietary Sonus Array Technology, the company aims to create affordable, high-performance diagnostic tools. For more information, visit www.sonusmicrosystems.com

About Kinetix MedicineKinetix Medicine is a Vancouver-based clinical services provider specializing in advanced clinical evaluations, patient-focused care, and a multidisciplinary approach to orthopaedic care.  Kinetix’ state-of-the-art equipment and techniques create successful patient outcomes for pain management and rehabilitation.  With expertise spanning multiple therapeutic areas, Kinetix partners with technology innovators to bring cutting-edge medical solutions to clinical practice. For more information, visit https://kinetixmedicine.com/

Media Contact:

Dr. Hani EskandariPresident & CEO, Sonus Microsystems media-relations@sonusmicrosystems.com